The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Valle, J., Wasan, H., Palmer, D. H., Cunningham, D., Anthoney, A., Maraveyas, A., Madhusudan, S., Iveson, T., Hughes, S., Pereira, S. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908721 · Cited by 4,406
Calamita, E., Schmid, M., Kunz, M., Ndebele-Murisa, M. R., Magadza, C. H. D., Nyambe, I., & Wehrli, B. (2019) · Figshare · doi:10.26181/6153922fe919c · Cited by 4,222
Wolff, A. C., Hammond, M. E. H., Hicks, D. G., Dowsett, M., McShane, L. M., Allison, K. H., Allred, D. C., Bartlett, J. M. S., Bilous, M., Fitzgibbons, P., et al. (2014) · Archives of Pathology and Laboratory Medicine · doi:10.5858/arpa.2013-0953-sa · Cited by 1,762
Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma
Livasy, C. A., Karaca, G., Nanda, R., Tretiakova, M. S., Olopade, O. I., Moore, D. T., & Perou, C. M. (2006) · Modern Pathology · doi:10.1038/modpathol.3800528 · Cited by 1,063
Moerlooze, L. D., Spencer-Dene, B., Revest, J.-M., Hajihosseini, M., Rosewell, I., & Dickson, C. (2000) · Development · doi:10.1242/dev.127.3.483 · Cited by 864
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
Wu, Y.-M., Su, F., Kalyana-Sundaram, S., Khazanov, N., Ateeq, B., Cao, X., Lonigro, R. J., Vats, P., Wang, R., Lin, S.-F., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0050 · Cited by 744
Cholangiocarcinoma: Advances in pathogenesis, diagnosis, and treatment†
Blechacz, B., & Gores, G. J. (2008) · Hepatology · doi:10.1002/hep.22310 · Cited by 681
Self-citationArai, Y., Totoki, Y., Hosoda, F., Shirota, T., Hama, N., Nakamura, H., Ojima, H., Furuta, K., Shimada, K., Okusaka, T., et al. (2014) · Hepatology · doi:10.1002/hep.26890 · Cited by 553
Andersen, J. B., Spee, B., Blechacz, B. R., Avital, I., Komuta, M., Barbour, A., Conner, E. A., Gillen, M. C., Roskams, T., Roberts, L. R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.005 · Cited by 552
Self-citationHistopathological Identification of Colon Cancer with Microsatellite Instability
Alexander, J., Watanabe, T., Wu, T.-T., Rashid, A., Li, S., & Hamilton, S. R. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63994-6 · Cited by 511
Fulford, L. G., Easton, D. F., Reis‐Filho, J. S., Sofronis, A., Gillett, C. E., Lakhani, S. R., & Hanby, A. (2006) · Histopathology · doi:10.1111/j.1365-2559.2006.02453.x · Cited by 352
Borad, M. J., Champion, M. D., Egan, J. B., Liang, W. S., Fonseca, R., Bryce, A. H., McCullough, A. E., Barrett, M. T., Hunt, K., Patel, M. D., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004135 · Cited by 344
Self-citationSurvey of Tyrosine Kinase Signaling Reveals ROS Kinase Fusions in Human Cholangiocarcinoma
Gu, T.-L., Deng, X., Huang, F., Tucker, M., Crosby, K., Rimkunas, V., Wang, Y., Deng, G., Zhu, L., Tan, Z., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015640 · Cited by 307
Iseki, S., Wilkie, A. O. M., & Morriss-Kay, G. M. (1999) · Development · doi:10.1242/dev.126.24.5611 · Cited by 305
Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma
Kipp, B. R., Voss, J. S., Kerr, S. E., Barr Fritcher, E. G., Graham, R. P., Zhang, L., Highsmith, W. E., Zhang, J., Roberts, L. R., Gores, G. J., et al. (2012) · Human Pathology · doi:10.1016/j.humpath.2011.12.007 · Cited by 244
Self-citationEmbryology of Extra‐ and Intrahepatic Bile Ducts, the Ductal plate
Roskams, T., & Desmet, V. (2008) · The Anatomical Record · doi:10.1002/ar.20710 · Cited by 236
Structural interactions of fibroblast growth factor receptor with its ligands
Stauber, D. J., DiGabriele, A. D., & Hendrickson, W. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.49 · Cited by 231
Related fibroblast growth factor receptor genes exist in the human genome.
Houssaint, E., Blanquet, P., Champion-Arnaud, P., Gesnel, M.-C., Torriglia, A., Courtois, Y., & Breathnach, R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.20.8180 · Cited by 151
Molecular profiling of cholangiocarcinoma shows potential for targeted therapy treatment decisions
Voss, J. S., Holtegaard, L. M., Kerr, S. E., Fritcher, E. G. B., Roberts, L. R., Gores, G. J., Zhang, J., Highsmith, W. E., Halling, K. C., & Kipp, B. R. (2013) · Human Pathology · doi:10.1016/j.humpath.2012.11.006 · Cited by 143
Self-citationFibroblast growth factor receptors, developmental corruption and malignant disease
Kelleher, F. C., O’Sullivan, H., Smyth, E. C., McDermott, R., & Viterbo, A. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt254 · Cited by 140
Rekhtman, N., Ang, D. C., Riely, G. J., Ladanyi, M., & Moreira, A. L. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.74 · Cited by 117
Wood, L. D., Heaphy, C. M., Daniel, H. D.-J., Naini, B. V., Lassman, C., Arroyo, M. R., Kamel, I. R., Cosgrove, D., Boitnott, J. K., Meeker, A. K., et al. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.68 · Cited by 80
Balaton, A., Sibony, M., Gotheil, C., Callard, P., & Baviéra, E. E. (1988) · The Journal of Pathology · doi:10.1002/path.1711560405 · Cited by 77
Shafizadeh, N., Grenert, J. P., Sahai, V., & Kakar, S. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.10.002 · Cited by 77
Cholangiocarcinoma: Is transplantation an option? For whom?
Gores, G. J., Nagorney, D. M., & Rosen, C. B. B. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.07.003 · Cited by 63
Self-citationLei, J.-Y., Bourne, P. A., diSant’Agnese, P. A., & Huang, J. (2006) · American Journal of Clinical Pathology · doi:10.1309/59tn-efal-ul5w-j94m · Cited by 57
and Functional Significance in the NewClassification of Primary Liver Cancers
Lo, R. C., & Ng, I. O. (2013) · Liver Cancer · doi:10.1159/000343844 · Cited by 44
A single-point mutation in FGFR2 affects cell cycle and Tgfβ signalling in osteoblasts
Lee, K. M. A., Santos‐Ruiz, L., & Ferretti, P. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.11.006 · Cited by 22
Advances in liver surgery for cholangiocarcinoma
DeOliveira, M. L., Kambakamba, P., & Clavien, P. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283600a92 · Cited by 16
Cited by
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Banales, J. M., Marin, J. J. G., Lamarca, A., Rodrigues, P. M., Khan, S. A., Roberts, L. R., Cardinale, V., Carpino, G., Andersen, J. B., Braconi, C., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0310-z · Cited by 2,411
Self-citationThe Fibroblast Growth Factor signaling pathway
Ornitz, D. M., & Itoh, N. (2015) · WIREs Developmental Biology · doi:10.1002/wdev.176 · Cited by 2,050
Cholangiocarcinoma — evolving concepts and therapeutic strategies
Ilyas, S. I., Khan, S. A., Hallemeier, C. L., Kelley, R. K., & Gores, G. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.157 · Cited by 1,626
Self-citationAbou-Alfa, G. K., Sahai, V., Hollebecque, A., Vaccaro, G., Melisi, D., Al-Rajabi, R., Paulson, A. S., Borad, M. J., Gallinson, D., Murphy, A. G., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30109-1 · Cited by 1,611
Self-citationLiver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Sia, D., Villanueva, A., Friedman, S. L., & Llovet, J. M. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.048 · Cited by 1,153
Metadata
- Authors
- Graham, R. P., Barr Fritcher, E. G., Pestova, E., Schulz, J., Sitailo, L. A., Vasmatzis, G., Murphy, S. J., McWilliams, R. R., Hart, S. N., Halling, K. C., Roberts, L. R., Gores, G. J., Couch, F. J., Zhang, L., Borad, M. J., & Kipp, B. R.
- Venue
- Human Pathology
- Publisher
- Elsevier BV
- Published
- 2014-08
- Volume
- 45
- Issue
- 8
- Pages
- 1630-1638
- ISSN
- 0046-8177 (ISSN-L)
- OpenAlex
- W2015613033
- Cited by
- 313
- References
- 29
- FWCI
- 17.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.